now loading...
Wealth Asia Connect Middle East Treasury & Capital Markets Europe ESG Forum TechTalk
On The Move
Xinrong names CEO
Xinrong Best Medical Instrument Co., one of China’s leading manufacturers of orthopedic implants for trauma, spine, and joint applications, has hired Yu (Christine) Zhang as CEO following Blackstone’s investment.
The Asset 8 Oct 2014

Xinrong Best Medical Instrument Co., one of China's leading manufacturers of orthopedic implants for trauma, spine, and joint applications, has hired Yu (Christine) Zhang as CEO following Blackstone's investment.

 

She was previously director of Stryker's China business. Her tenure spanned nearly eight years and included several leadership positions in the orthopedics and medsurg franchises. Zhang has nearly 20 years of experience in the medical device and pharmaceutical industries with a strong track record for driving business results.

 

In September this year, funds managed by global asset manager Blackstone made a significant investment into Xinrong.

 

Conversation
David Wong
David Wong
senior investment strategist, equities
Alliance Bernstein
- JOINED THE EVENT -
7th Taiwan Investment Summit - Webinar Series 2021
Transitioning to a green future
View Highlights
Conversation
Serena Tan
Serena Tan
senior analyst, responsible investments
Nordea Asset Management
- JOINED THE EVENT -
In-person roundtable
Tech in ESG
View Highlights